APTAMER: A REVIEW ON ITS IN VITRO SELECTION AND DRUG DELIVERY SYSTEM
Keywords:Aptamer, SELEX, Biosensors, Novel drug delivery system, Nanoparticle, Diagnosis
In recent year, Aptamer has been one of the key tools in the field of advanced drug delivery systems. Aptamer are oligonucleotides or peptides that bind to a specific target molecule. In this review we summarize the major differences between the antibody and an Aptamer along with the different methodology of the In vitro selection of the Aptamer by using SELEX (Systematic evolution of ligands by exponential enrichment) technique. SELEX is a technique which has a based biosensors and some of the novel drug delivery system. The article referred in this review was referred from the above said source was in the range of 1990-2020 years.
Primary contents is searched from science direct, springer nature, scopus indexed journals. The resources are downloaded from google scholar, peer-reviewed published literature from scientific journals and books.
Search criteria: The primary contents are searched from science direct, springer nature, scopus indexed journals. The resources are downloaded from google scholar, peer-reviewed published literature from scientific journals and books.
Song KM, Lee S, Ban C. Aptamer and their biological application. Sensor. 2012; 12: 612-31.
Capra, John A, Paeschke, Katrin, Singh, Mona, Zakian, Virginia A. Stormo, Gary D. G-Quadruplex DNA Sequences Are Evolutionarily Conserved and Associated with Distinct Genomic Features in Saccharomyces cerevisiae. PLOS Computational Biology.2010;6: e1000861.
Ellington AD and Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346: 818–22.
Gold L, Janjic N, Jaruis T, Schneider D, Walker JJ, Wilcox SK, Zinchi D. Aptamer and RNA world past and present. Cold Spring Harb Perspect Biol 2012; 4:1-9.
Gold L. A personal perspective: Aptamer after 15 years. The Aptamer handbook. 2006; 461-69.
Yanling Song, Jia Song, Xinyu Wei, Mengjiao Huang, Miao Sun. Discovery of Aptamer Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein. Anal Chem. 2020; 92: 9895–900.
Krüger A, De Jesus Santos AP, De Sa V, Ulrich H, Wrenger C. Aptamer Applications in Emerging Viral Diseases. Pharmaceuticals. 2021; 14:1-19.
Hyebin Yoo, Hyesung Jo and Seung Soo Oh. Detection and beyond: challenges and advances in aptamer-based biosensors. Mater Adv. 2020; 1:2663-87.
Turek C. Gold L. Systematic evolution of ligand by exponential enrichment: RNA ligand to bacteriophage T4 DNA polymerase. Science. 1990; 249:505-10.
Gopinath SCB. Method developed for SELEX. Anal bioanal chem. 2007; 387:171-82.
Tombelli S, Minunni M, Mascini M. Analytical application of Aptamer. Biosensor and bioelectronics. 2005; 20: 2424-34.
Song KM, Cho M, Jo H, Min K, Jeon SH, Kim T, Han MS, Ku JK, Ban C. Gold nanoparticle – based colorimetric detection of kanamycin using a DNA Aptamer. Analytical biochemistry. 2011; 415:175-81.
Vianini E, Palumbo M, Gatto B. In vitro selection of DNA Aptamer that bind L-Tyrosinamide. Bio-organic and Medicinal chemistry. 2001; 9: 2543-48.
Levesque D, Beaudoin JD, Roy S, Perreault JP. In vitro selection and characterization of RNA Aptamer binding thyroxine hormone. Biochem J. 2007; 403:129-38.
Joeng CB, Niazi JH, Lee SJ, GU MB. ssDNA Aptamer that recognize diclofenac and 2-anilinophenylacetic acid. Bioorg Med chem.2009; 17:5380-587.
Mendonsa SD, Bowser MT. In vitro selection of Aptamer with affinity for neuropeptide Y using capillary electrophoresis. J Am chem soc. 2005; 127:9382-83.
Mendonsa SD, Bowser MT. In vitro selection of high affinity DNA ligands for human IgE using capillary electrophoresis. Anal chem. 2004; 76: 5387-92.
Lou X, Qian J, Xiao Y, Viel L, Gerdon AE, Lagally ET, Atzberger P, Tarasow TM, Heeger AJ, Soh HT. Micromagnetic selection of Aptamer in microfluidic channels. Proc Natl Acad Sci USA. 2009; 106:2989-994.
Huang CJ,Lin HI, Shiesh SC, Lee GB. Integrated microfluidic system for rapid screening of CRP Aptamer utilizing systematic evolution of ligand by exponential enrichment [SELEX]. Biosensor Bioelectron. 2010; 25:1761-66.
Chen M, Yu Y, Jiang F , Zhou J , Li Y , Liang C , Dang J, Lu A , Zhang G. Development of cell SELEX technology and its application in cancer diagnosis and therapy.
Int J Mol Sci. 2016; 17:1-14.
Kaur H. Recent development in cell SELEX technology for Aptamer selection. BBA-General subjects. 2018; 1862:2323-29.
Mayer G, Ahmed MS. Fluorescence-activated cell sorting for Aptamer SELEX with cell mixtures. Nat Protoc. 2010; 5:1993–2004.
Homann M, Goringer HU. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 1999; 27:2006–14.
Homann M, Göringer HU. Uptake and intracellular transport of RNA Aptamer in African trypanosomes suggest therapeutic "piggy-back" approach. Bioorg Med Chem. 2001; 9: 2571–80.
Haisler WL, Timm DM, Gage JA, Tseng H, Killian TC, Souza GR. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013; 8:1940–49.
Guthold M, Cubicciotti R, Superfi HE. Zumrut. Ligand-Guided selection of target-specific Aptamer: a screening technology for identifying specific Aptamer against cell-surface proteins. Nucleic Acid Ther 2016; 26:190–8.
Hicke BJ, Marion C, Chang YF, Gould T, Lynott CK, Parma D, Schmidt PG, Warren S. Tenascin-C Aptamer are generated using tumor cells and purified protein. J Biol Chem. 2001; 276: 48644–654.
Guthold M, Cubicciotti R, Superfine R, Taylor RM. Novel methodology to detect, isolate, amplify and characterize single aptamer molecules with desirable target-binding properties. Biophys J. 2002; 82: 797.
Khati M, Schuman M, Ibrahim J, Sattentau Q, Gordon S, James W. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 bygp120-binding 2′F-RNA Aptamer. J Virol. 2003; 77:12692–98.
Tsai RY, Reed RR. Identification of DNA recognition sequences and protein interaction domains of the multiple-Zn-finger protein Roaz. Mol Cell Biol. 1998; 18: 6447–56.
Misono TS, Kumar PK. Selection of RNA Aptamer against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem. 2005; 342: 312–17.
Kyung-Mi Song, Seonghwan Lee and Changill Ban. Aptamer and their biological applications. Sensors. 2012; 12: 612-31.
Numnuam A, Chumbimuni-Torres KY, Xiang, Y, Bash R, Thavarungkul P, Kanatharana P, Pretsch E, Wang J, Bakker E. Aptamer-based potentiometric measurements of proteins using ion-selective microelectrodes. Anal Chem. 2008; 80:707–12.
Feng, K, Sun C, Kang Y, Chen J, Jiang JH, Shen GL, Yu RQ. Label-free electrochemical detection of nanomolar adenosine based on target-induced Aptamer displacement Electrochem Commun. 2008; 10: 531–35.
Xu D, Xu D, Yu X, Liu Z, He W, Ma Z. Label-free electrochemical detection for Aptamer-based array electrodes. Anal. Chem. 2005; 77: 5107–113.
Wang X, Zhou J, Yun W, Xiao S, Chang, Z, He P, Fang, Y. Detection of thrombin using electrogenerated chemiluminescence based on Ru(bpy)3 2+-doped silica nanoparticle aptasensor via target protein-induced strand displacement. Anal Chim Acta. 2007; 598: 242–48.
Cho EJ, Lee JW, Ellington AD. Applications of Aptamer as sensors. Annu Rev Anal Chem.2009; 2:241–64.
Ikebukuro K, Kiyohara C, Sode K. Novel electrochemical sensor system for protein using the Aptamer in sandwich manner. Biosens Bioelectron. 2005; 20:2168–72.
Stojanovic MN, De Prada P, Landry DW. Aptamer-based folding fluorescent sensor for cocaine. J Am Chem Soc. 2001; 123: 4928–31.
Zhao W, Chiuman W, Brook MA, Li.Y. Simple and rapid colorimetric biosensors based on DNA Aptamer and noncrosslinking gold nanoparticle aggregation. Chem Bio Chem 2007; 8:727–31.
Luzi E, Minunni M, Tombelli S, Mascini M. New trends in affinity sensing: Aptamer for ligand binding. Trends Anal Chem. 2003; 22: 810–18.
Hianik. T, Ostatna.V, Zajacova. Z, Stoikova. E, Evtugyn. G. Detection of Aptamer-protein interactions using QCM and electrochemical indicator methods. Bioorg Med Chem Lett. 2005; 15: 291–95.
Byun, J. Recent Progress and Opportunities for Nucleic Acid Aptamer. Life. 2021; 11: 1-18.
Kang H, O’Donoghue MB, Liu H, Tan W. A liposome based nanostructure for Aptamer directed delivery. Chem commun. 2010; 46:249-51.
Hallahan D, Geng L, Qu S, Scarfone C, Giorgio, Donnelly E and Gao X. Integrin-mediated Targeting of Drug Delivery to Irradiated Tumor Blood Vessels. Cancer Cell. 2003; 3: 63–74.
Tang Y,Hu H, Zhang MG, Song J, Nie J, Wang S, Niu G, Huang P, Lu G, Chen X. Aptamer-targeting photosensitive drug delivery system off-on Graphene oxide wrapped mesoporous silica nanoparticle. Nanoscale. 2015; 7:6304–10.
Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterial.2011; 32:8010-20.
Zhao N, You J, Zeng Z, Li C,Zu Y. An ultra pH-sensitive and Aptamer equipped nanoscale drug delivery system for selective killing of tumor cells. Small.2013; 1-3.
How to Cite
Copyright (c) 2021 VINOD KUMAR, BRITO RAJ S., LAKSHMI KANAKARAJ, DEEVAN PAUL A., KAVITHA K., RAVI M., SUCHARITHA P.
This work is licensed under a Creative Commons Attribution 4.0 International License.